About Nura Bio
Developing neurotherapeutics to halt serious diseases before they progress too far
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
South San Francisco, United States
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
nurabio.com
Domain Registered Date
Oct 10, 2019
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $73,800,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $68,000,000 · Series-A
fundraisingfox.com
- Milestone
X account created (@nurabio_)
58 followers
- Milestone
Website domain registered
nurabio.com
Investors & Backers
Euclidean Capital
Samsara Biocapital
Sanofi Ventures
The Column Group
Funding History
Series-B+
· Jun 22, 2026
$73,800,000 fundraisingfox.com
Series-A
· Sep 18, 2024
$68,000,000 fundraisingfox.com
Founders & Leadership
Andrew Pieper
Founder
Work email & phone locked
Unlock →
David Hewitt
Senior Vice President
Work email & phone locked
Unlock →
MARC FREEMAN
Co-Founder
Work email & phone locked
Unlock →
STEVE MCKNIGHT
Co-Founder
Previously / Related: Flare Therapeutics
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026